Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis.

"Conflicts of interest: J. Weatherald reports grants or contracts from Janssen, Actelion, Bayer, Canadian Institutes for Health Research and Heart & Stroke Foundation of Canada; consulting fees from Janssen and Actelion; honoraria from Janssen; payment for expert testimony from Spigings Intellectual Property Law; travel support from Janssen; and participation on a Data Safety Monitoring Board or Advisory Board for Janssen, Acceleron and Université Laval. J. Weatherald is a member of the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada. He is a shareholder in a pulmonary function testing laboratory (Precision Lung Consultants and Diagnostics). All other authors have no conflicts to declare."

"Conflicts of interest: J. Weatherald reports grants or contracts from Janssen, Actelion, Bayer, Canadian Institutes for Health Research and Heart & Stroke Foundation of Canada; consulting fees from Janssen and Actelion; honoraria from Janssen; payment for expert testimony from Spigings Intellectual Property Law; travel support from Janssen; and participation on a Data Safety Monitoring Board or Advisory Board for Janssen, Acceleron and Université Laval. J. Weatherald is a member of the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada. He is a shareholder in a pulmonary function testing laboratory (Precision Lung Consultants and Diagnostics). All other authors have no conflicts to declare."

"The protocol for this systematic review was pre-specified and was registered on the PROSPERO international prospective register of systematic reviews (CRD42020186110) on 5 July 2020 and is reported according to the PRISMA 2020 statement (table S1) []."